Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

JNJ 107.04 +1.48 (1.40%)
price chart
Johnson & Johnson heiress pens book
A decade ago, Johnson & Johnson heir Jamie Johnson won acclaim for profiling pampered pals including Ivanka Trump and Georgina Bloomberg in his HBO doc, ´┐ŻBorn Rich.
Johnson & Johnson Plans Ebola Vaccine Testing
Johnson & Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus.
Johnson & Johnson accelerates Ebola vaccine testing amid heightened anxiety  The Star-Ledger
Ebola: Johnson & Johnson to start vaccine trials in January
Related articles »  
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Higher
The Dow component leading the way higher looks to be Johnson & Johnson (NYSE: JNJ), which is sporting a 22-cent gain (+0.2%) bringing the stock to $105.78.
Related articles »  
John J. Heldrich, former top executive at Johnson & Johnson and civic leader ...
Widely considered one of New Jersey's top business and civic leaders, Heldrich spent 41 years at Johnson & Johnson before retiring in 1991.
Johnson & Johnson to Begin Testing Ebola Vaccine in January
Johnson & Johnson said it would begin testing an Ebola-virus vaccine in humans in January and could have 250,000 doses available in May, if health authorities deem it safe and promising enough to distribute more broadly.
Johnson & Johnson introduce Ebola vaccine; clinical trials to start in ...
Related articles »  
Johnson & Johnson's DePuy wins first trial over Pinnacle hips
NEW YORK/DALLAS (Reuters) - Johnson & Johnson was found not liable by a Texas jury on Thursday in the first case to go to trial over whether Pinnacle hip implants made by the company's DePuy Orthopedics unit were defective.
Why Johnson & Johnson (JNJ) Stock Is Higher Today
Johnson & Johnson Wins First Pinnacle Hip Implant Trial  Businessweek
Related articles »  
One Put, One Call Option To Know About for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call ...
Related articles »  
John Heldrich remembered as visionary
John J. Heldrich, of Highland Park, retired vice president of administration and retired member of the Executive Committee and Board of Directors at Johnson & Johnson, died Tuesday at 88. Heldrich also was the founder of New Brunswick Tomorrow, the ...
Related articles »  
Market Reaction To Johnson & Johnson's Earnings Is Justified
Johnson & Johnson's stock price fell sightly following its Q3 2014 earnings announcement despite the company beating consensus estimates and keeping the full year outlook the same.
Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for ...
BOSTON--(BUSINESS WIRE)--The Joslin Institute for Technology Translation (JITT) today announced that three Johnson & Johnson Diabetes Solutions Companies, LifeScan, Inc., Animas Corporation and Calibra Medical, Inc., have joined JITT as Founding ...
Related articles »